Tag: Mydecine - Page 7 - Psychedelic Alpha

Read more about the article Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

Post published:February 3, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Post published:February 1, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Post published:January 28, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Files Application to list to the NASDAQ

Mydecine Innovations Group Files Application to list to the NASDAQ

Post published:January 27, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

Post published:January 21, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Post published:January 14, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer

Post published:January 11, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Shares Intellectual Property Update

Mydecine Innovations Group Shares Intellectual Property Update

Post published:January 7, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

Post published:January 5, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Post published:December 21, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.